Eligibility for mechanical thrombectomy in acute ischemic stroke

A phase IV multi-center screening log registry

Georgios Tsivgoulis, Nitin Goyal, Robert Mikulik, Vijay K. Sharma, Aristeidis H. Katsanos, Ramin Zand, Prakash R. Paliwal, Andromachi Roussopoulou, Ondrej Volny, Abhi Pandhi, Christina Zompola, Lucas Elijovich, Apostolos Safouris, Jason Chang, Andrei Alexandrov, Anne Alexandrov

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67 ± 14 years, 56% men, median admission NIHSS-score: 5, IQR: 3–10). A total of 123 (8%, 95% CI: 7%–10%) and 82 (6%, 95% CI: 5%–7%) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p > 0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69%) and hospital arrival outside the eligible time window (38% for MR CLEAN & 35% for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.

Original languageEnglish (US)
Pages (from-to)96-99
Number of pages4
JournalJournal of the Neurological Sciences
Volume371
DOIs
StatePublished - Dec 15 2016

Fingerprint

Thrombectomy
Registries
Stroke
Tertiary Care Centers
Multicenter Studies
Reperfusion
Safety
Population

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Eligibility for mechanical thrombectomy in acute ischemic stroke : A phase IV multi-center screening log registry. / Tsivgoulis, Georgios; Goyal, Nitin; Mikulik, Robert; Sharma, Vijay K.; Katsanos, Aristeidis H.; Zand, Ramin; Paliwal, Prakash R.; Roussopoulou, Andromachi; Volny, Ondrej; Pandhi, Abhi; Zompola, Christina; Elijovich, Lucas; Safouris, Apostolos; Chang, Jason; Alexandrov, Andrei; Alexandrov, Anne.

In: Journal of the Neurological Sciences, Vol. 371, 15.12.2016, p. 96-99.

Research output: Contribution to journalArticle

Tsivgoulis, Georgios ; Goyal, Nitin ; Mikulik, Robert ; Sharma, Vijay K. ; Katsanos, Aristeidis H. ; Zand, Ramin ; Paliwal, Prakash R. ; Roussopoulou, Andromachi ; Volny, Ondrej ; Pandhi, Abhi ; Zompola, Christina ; Elijovich, Lucas ; Safouris, Apostolos ; Chang, Jason ; Alexandrov, Andrei ; Alexandrov, Anne. / Eligibility for mechanical thrombectomy in acute ischemic stroke : A phase IV multi-center screening log registry. In: Journal of the Neurological Sciences. 2016 ; Vol. 371. pp. 96-99.
@article{e1dec225242a4ec08eca479a67a63ce9,
title = "Eligibility for mechanical thrombectomy in acute ischemic stroke: A phase IV multi-center screening log registry",
abstract = "No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67 ± 14 years, 56{\%} men, median admission NIHSS-score: 5, IQR: 3–10). A total of 123 (8{\%}, 95{\%} CI: 7{\%}–10{\%}) and 82 (6{\%}, 95{\%} CI: 5{\%}–7{\%}) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p > 0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69{\%}) and hospital arrival outside the eligible time window (38{\%} for MR CLEAN & 35{\%} for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.",
author = "Georgios Tsivgoulis and Nitin Goyal and Robert Mikulik and Sharma, {Vijay K.} and Katsanos, {Aristeidis H.} and Ramin Zand and Paliwal, {Prakash R.} and Andromachi Roussopoulou and Ondrej Volny and Abhi Pandhi and Christina Zompola and Lucas Elijovich and Apostolos Safouris and Jason Chang and Andrei Alexandrov and Anne Alexandrov",
year = "2016",
month = "12",
day = "15",
doi = "10.1016/j.jns.2016.10.018",
language = "English (US)",
volume = "371",
pages = "96--99",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Eligibility for mechanical thrombectomy in acute ischemic stroke

T2 - A phase IV multi-center screening log registry

AU - Tsivgoulis, Georgios

AU - Goyal, Nitin

AU - Mikulik, Robert

AU - Sharma, Vijay K.

AU - Katsanos, Aristeidis H.

AU - Zand, Ramin

AU - Paliwal, Prakash R.

AU - Roussopoulou, Andromachi

AU - Volny, Ondrej

AU - Pandhi, Abhi

AU - Zompola, Christina

AU - Elijovich, Lucas

AU - Safouris, Apostolos

AU - Chang, Jason

AU - Alexandrov, Andrei

AU - Alexandrov, Anne

PY - 2016/12/15

Y1 - 2016/12/15

N2 - No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67 ± 14 years, 56% men, median admission NIHSS-score: 5, IQR: 3–10). A total of 123 (8%, 95% CI: 7%–10%) and 82 (6%, 95% CI: 5%–7%) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p > 0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69%) and hospital arrival outside the eligible time window (38% for MR CLEAN & 35% for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.

AB - No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67 ± 14 years, 56% men, median admission NIHSS-score: 5, IQR: 3–10). A total of 123 (8%, 95% CI: 7%–10%) and 82 (6%, 95% CI: 5%–7%) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p > 0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69%) and hospital arrival outside the eligible time window (38% for MR CLEAN & 35% for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.

UR - http://www.scopus.com/inward/record.url?scp=84992530224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992530224&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2016.10.018

DO - 10.1016/j.jns.2016.10.018

M3 - Article

VL - 371

SP - 96

EP - 99

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -